drugset / Trial / NCT01317433
Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to test the role of cycline in the prevention of acne-like skin rash in metastatic colorectal patients treated with Cetuximab and intensified FOLFIRI.
Timeline
- Start
- 2010-12-29
- Primary completion
- 2016-10-10
- Completion
- 2016-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxycycline | Small molecule | 100 mg | Oral |
| Background | Cetuximab | Monoclonal antibody | 500 mg/m2 | Intravenous |